Innovative Approaches to Managing Oral Submucous Fibrosis: A Case Report and Review of Emerging Treatment Modalities

Oral submucous fibrosis (OSF) is a chronic, progressive condition of the oral cavity, marked by juxta-epithelial inflammatory reaction and subsequent fibrosis of the submucosal tissues, leading to restricted mouth opening, oral burning sensation, and potential malignant transformation. The condition is prevalent in South and Southeast Asia, primarily due to the use of areca nut and other chewing habits. This case report presents an innovative treatment approach utilizing a novel combination of antifibrotic agents, regenerative therapy, and laser surgery, which has shown significant promise in reducing fibrosis and improving functionality. We review recent developments in therapeutic strategies, focusing on regenerative medicine, bioengineering, and minimally invasive techniques that are not yet widely adopted. The case highlights the potential for novel bioactive materials and emerging technologies such as platelet-rich plasma (PRP) in reducing fibrosis and enhancing tissue healing. The article contributes to the growing body of literature on OSF management and underscores the need for further clinical trials to evaluate these new modalities.